A process for the preparation of (3aR,4S, 6R, 6aS)-6-amino-2, 2dimethyltetrahydro-3aH-cyclopenta[d] [1,3] dioxol-4-ol dibenzoyl-L-tartrate and to products of said process

Details for Australian Patent Application No. 2008321575 (hide)

Owner AstraZeneca AB

Inventors Magnusson, Mattias; Bohlin, Martin Hans; Lindblad, Ulrika; Aufdenblatten, Rhony; Ducry, Laurent

Agent Davies Collison Cave

Pub. Number AU-B-2008321575

PCT Pub. Number WO2009/064249

Priority 60/988,121 15.11.07 US

Filing date 14 November 2008

Wipo publication date 22 May 2009

Acceptance publication date 5 July 2012

International Classifications

C07D 317/44 Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms

Event Publications

27 May 2010 PCT application entered the National Phase

  PCT publication WO2009/064249 Priority application(s): WO2009/064249

5 July 2012 Application Accepted

  Published as AU-B-2008321575

1 November 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008321577-Bis-(sulfonylamino) derivatives in therapy 066

2008321570-Method for processing of pozzolans.